Here are 5 tips to avoid a liver disorder:

  1. CHOOSE YOUR FATS WISELY: Dietary fat is a confusing concept for the public, with both evolving science over time and areas of remaining uncertainty in the scientific literature. The resulting communication challenges are amplified by the complexities of evidence related to isolated nutrients vs. types of foods vs. overall dietary patterns. While each of these types of concepts can inform evidence-based nutrition science, and resulting dietary recommendations, they should not be considered in isolation without considering the overall types and quality of evidence.  Also the types of fat and carbohydrates – and more relevantly, the types of foods supplying these nutrients – are more important than the total amounts of fats and carbohydrates in the diet. Healthful plant and seafood sources of monounsaturated and polyunsaturated fats have important health benefits in the context of a healthy dietary pattern. Future dietary recommendations should focus on healthful dietary patterns to help consumers identify and choose foods that are good sources of healthy fats. 
  2. KEEP A NOTE OF ANTIOXIDANTS: Investigations of antioxidants show that compounds in food are candidates for the treatment of several diseases because they improve the antioxidant system in the body, especially when the disease involves oxidative stress. antioxidants that can be investigated for experimental and clinical trials and will be used for the treatment of liver diseases such as liver cirrhosis. Curcumin, quercetin, and naringenin are effective in the treatment of experimental liver injury, and they can be studied in clinical trials. Green tea has been shown to protect against different kinds of cancer in clinical trials, except in hepatocellular carcinoma. Conversely, there are no clinical trials investigating resveratrol, coffee, and silymarin. However, the data are poor or contradictory, and it is necessary to perform more clinical trials to use these antioxidants for the treatment of liver diseases in patients.
  3. A STRICT NO TO ALCOHOL INTAKE: The lack of common data elements/standardized definitions of various terms that are included under the term “malnutrition” has resulted in difficulty in interpreting data from different groups. Because sarcopenia is the major component of “malnutrition”, future studies evaluating interventions should include sarcopenia as an outcome measure. Because muscle mass changes slowly over time, other more acute measures are needed including changes in resting energy expenditure and respiratory quotient using the relatively easily accessible handheld calorimeters. Increasing calories and high-quality proteins alone are clearly insufficient and targeting molecular and metabolic perturbations is likely to be a more successful strategy. The anticipated increase in proportion and number of patients with ALD in the next decades, limited therapeutic armamentarium to treat alcohol use, and continued organ shortage for transplantation make it imperative to develop novel and effective non-transplant treatments for ALD. Improving muscle mass is expected to increase survival, improve quality of life and lower the incidence of other complications in patients and should form a priority area for future clinical studies in patients with ALD.
  4. KEEP A CHECK ON WEIGHT: NAFLD is common, and its prevalence is likely to increase with the rising incidence of obesity and diabetes. A minority of patients with NAFLD, particularly those with NASH and diabetes, are at risk of liver-related complications such as cirrhosis and hepatocellular carcinoma. In addition, the overall mortality appears to be higher among NAFLD patients than among people in the general population, probably because of underlying pathogenic factors such as insulin resistance. Currently, treatment is limited to weight loss, exercise and the control of metabolic risk factors. Effective pharmacotherapies are awaited, and several promising agents are on the horizon.
  5. ADD ON TO FIBER: RESMENA diet may be a valid strategy to counteract MS features and liver damage accompanying obesity. In addition, the type of dietary fibre differentially impacts liver health status in obese subjects under energy restriction. However, these results should be interpreted with caution, since other components contained in fruits, in addition to fruit fibre, could be involved in the observed benefits.